Swarna Varma, MD
Endocrinology, Diabetes & Metabolism · Pittsburgh, PANPI 1073599445
Payments from drug & device makers
Across 1,543 payments — averaging $337.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$355K
- Amarin Pharma, Inc.$49K
- AstraZeneca$29K
- Sanofi-aventis U.S. LLC$24K
- Bayer$23K
- Merck$13K
- plus $28K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 772 | $355,258 |
| Amarin Pharma, Inc. | 93 | $49,105 |
| AstraZeneca(2 entities) | 101 | $28,846 |
| Sanofi-aventis U.S. LLC | 88 | $23,566 |
| Bayer | 65 | $23,226 |
| Merck | 58 | $12,752 |
| AbbVie | 69 | $9,969 |
| Esperion Therapeutics, Inc. | 14 | $5,741 |
| Abbott | 25 | $3,822 |
| Medtronic(2 entities) | 48 | $2,477 |
| Tandem Diabetes Care, Inc. | 3 | $1,796 |
| Amneal Pharmaceuticals LLC | 53 | $1,476 |
| BD | 20 | $374 |
| Novo Nordisk | 32 | $331 |
| Dexcom, Inc. | 25 | $310 |
| Amgen | 12 | $181 |
| Kowa Pharmaceuticals America, Inc. | 14 | $173 |
| Xeris Pharmaceuticals, Inc. | 6 | $97 |
| Sanofi | 1 | $90 |
| Embecta Corp. | 5 | $85 |
| Ascendis Pharma Endocrinology Inc | 4 | $78 |
| Corcept Therapeutics | 4 | $71 |
| Boehringer Ingelheim | 4 | $69 |
| Insulet Corporation | 3 | $52 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $46 |
| Pfizer | 2 | $40 |
| BETA Bionics, Inc. | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $32 |
| IBSA Pharma Inc. | 2 | $31 |
| Zealand Pharma US, Inc. | 2 | $31 |
| Amphastar Pharmaceuticals, Inc. | 2 | $30 |
| Novartis | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $17 |
| GRT US Holding, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Lifescan, Inc. | 1 | $13 |
How this compares
$520,355 in reported general payments places this provider in the 95th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.
See all endocrinology, diabetes & metabolism providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Pittsburgh
- Vijay BahlPittsburgh$998K
- Erin KershawPittsburgh$804K
- Murray GordonPittsburgh$576K
- Sachin BahlPittsburgh$162K
- Peter GrondziowskiPittsburgh$143K
- Patricia BononiPittsburgh$107K
- Frederico ToledoPittsburgh$92K
- Esra Karslioglu FrenchPittsburgh$73K
- Mona Al MukaddamPhiladelphia$3.9M
- Serge JabbourPhiladelphia$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.